Skip to Content Top

OVER $2.5 BILLION

OBTAINED FOR MESOTHELIOMA PATIENTS & FAMILIES
IARC Logo
|

French Health Agency Announces Link between Asbestos Exposure and Laryngeal and Ovarian Cancers

IARC Logo

The French National Health Security Agency (ANSES) issued a press release September 19, 2022, announcing a link between asbestos exposure and laryngeal and ovarian cancers. According to ANSES, between 150 to 170 diagnosis of these cancers each year are attributed to exposure to asbestos.

The International Agency for Research on Cancer (IARC) established the causal link between laryngeal and ovarian cancers and exposure to asbestos in 2012, but Alexandra Papadopoulos, scientific coordinator at ANSES stated that during her research, the majority of medical providers she spoke with were not aware of the potential link. “Asbestos is commonly associated with cancers of the lungs and the pleura, neither doctors nor patients make the link with other cancers”.

Several French health ministries are coordinating to develop Occupational Disease Tables listing laryngeal and ovarian cancers as occupational diseases to establish a Presumption of Origin help facilitate the link for patients and doctors to determine treatment options and assist patients whose disease was caused by asbestos who are seeking compensation.

Our Mission

  • Medical Empowerment

    Get the information you need to make informed decisions about your treatment.

  • Legal Empowerment

    Get the compensation you need to address the financial cost of your illness.

  • Going For The Gold

    Helping empower our clients with over $2.5 Billion in recoveries. We fight for our clients!

  • Giving Back To The Community

    Unprecedented Support for Mesothelioma Research. See how we can help!

Get Empowered

We put your medical and personal needs first and provide compassionate representation.
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.
  • By submitting, you agree to be contacted about your request & other information using automated technology. Message frequency varies. Msg & data rates may apply. Text STOP to cancel. Acceptable Use Policy